| Identification | Back Directory | [Name]
Thalidomide-NH-PEG1-NH-Boc | [CAS]
2154342-17-1 | [Synonyms]
Thalidomide-NH-PEG1-NH-Boc
Thalidomide-4-NH-PEG1-NH-Boc
Thalidomide-4-NH-PEG1-C2-NH-Boc
tert-butyl (2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethyl)carbamate
Carbamic acid, N-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethyl]-, 1,1-dimethylethyl ester | [Molecular Formula]
C22H28N4O7 | [MOL File]
2154342-17-1.mol | [Molecular Weight]
460.48 |
| Hazard Information | Back Directory | [Uses]
Thalidomide-4-NH-PEG1-NH-Boc is a Boc-modified Thalidomide (HY-14658) that acts as a Cereblon ligand to recruit CRBN protein. The Boc protecting group at the end of Thalidomide-4-NH-PEG1-NH-Boc can be removed under acidic conditions to participate in the synthesis of PROTAC molecules. Thalidomide-4-NH-PEG1-NH-Boc is a key intermediate in the synthesis of CRBN-based PROTAC molecules. | [IC 50]
Cereblon | [References]
[1] Fischer ES, et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014 Aug 7;512(7512):49-53.??[Content Brief] DOI:10.1038/nature13527 |
|
|